Alx Oncology Holdings (ALXO) Long-Term Investments (2022 - 2026)

Alx Oncology Holdings' Long-Term Investments history runs 5 years deep, the most recent figure standing at $28.8 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 214.19% year-over-year to $28.8 million; the TTM figure through Mar 2026 stood at $28.8 million (up 214.19% YoY), while the FY2025 annual figure was $3.5 million, down 0.85% from the prior year.
• Long-Term Investments came in at $28.8 million for Q1 2026 at Alx Oncology Holdings, up from $3.5 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $35.4 million in Q4 2023 to a low of $3.5 million in Q4 2025.
• A 5-year average of $15.8 million and a median of $11.6 million in 2023 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments tumbled 90.05% in 2024 and surged 214.19% in 2026, its largest moves.
• Alx Oncology Holdings' Long-Term Investments stood at $16.7 million in 2022, then jumped by 112.05% to $35.4 million in 2023, then sank by 90.05% to $3.5 million in 2024, then slipped by 0.85% to $3.5 million in 2025, then soared by 723.78% to $28.8 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $28.8 million, $3.5 million, and $5.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison